Compounds for site-enhanced delivery of radionuclides

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546147, 546168, 546169, 546170, 546174, 546175, 546314, 546318, C07D21510, C07D21516, C07D21712, C07D21355, C07D21356

Patent

active

051552272

ABSTRACT:
A dihydropyridine.revreaction.pyridinium salt type of redox, or chemical, delivery system for the site-specific and/or site-enhanced delivery of a radionuclide to the brain. A chelating agent capable of chelating with a radionuclide and having a reactive hydroxyl, carboxyl, amino, amide or imide group is coupled to a carrier moiety comprising a dihydropyridinie.revreaction.pyridinium salt nucleus and then complexed with a radionuclide to provide a new radionuclide pharmaceutial that, in its lipoidal dihydropyridine form, penetrates the blood-brain barrier (`BBB`) and allows increased levels of radionuclide concentration in the brain, particularly since oxidation of the dihydropyridine carrier moiety in vivo to the ionic pyridinium salt retards elimination from the brain while elimination from the general circulation is accelerated. This radionuclide delivery system is well suited for use in scintigraphy and similar radiographic techniques.

REFERENCES:
patent: 3823076 (1974-07-01), Rushmere et al.
patent: 4775763 (1988-10-01), Dolton et al.
patent: 4963688 (1990-10-01), Bodor

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Compounds for site-enhanced delivery of radionuclides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds for site-enhanced delivery of radionuclides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds for site-enhanced delivery of radionuclides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1301757

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.